Release date: 2014-09-09
I remember that at the end of last year, I saw the results of an international Alzheimer's Association. The number of Alzheimer's patients in the world has exceeded 44 million, and it is likely to reach 76 million by 2030. This is really a big market. It is no wonder that so many manufacturers have to develop anti-lost smart watches for these elderly people.
According to VB news, South Korean startup Ybrain, which produces masks for the treatment of Alzheimer's disease, has recently received $3.5 million in new financing, led by Stonebridge Capital, and will be used primarily for new clinical trials and production.
Founded in 2013, Ybrain was founded by neuroscientist Kyongsik Yun and Samsung engineers, which manufacture headbands for the treatment of Alzheimer's disease. The headband has a built-in sensor that stimulates brain activity and can be used for 30 minutes a day to alleviate the symptoms of Alzheimer's disease. It is said that this treatment is better than medical treatment, which is 20%-30% higher than oral efficacy, which is one of the keys to their financing.
Ybrain also has competitors, mainly wearer device manufacturer Soterix Medical. Previous analysts predicted that it is likely that there will be no new oral medications for Alzheimer's disease until 2025, so companies like Ybrain and Soterix Medical will likely have an impact on global pharmaceutical companies like Pfizer and Novartis.
But unfortunately, users can't buy Ybrain now, and they need to wait for Ybrain to complete clinical trials and register with the Food and Drug Administration in the US and Korea.
Source: 36Kr
Safety belt fittings
Safety belt fittings
Shandong Binzhou Yong'an Labor Protection Factory , https://www.zhuqiangsafetybelt.com